← All companies

Science / Company profile

Chemify

What Chemify does

Chemify is an AI-for-science company digitizing chemical discovery and synthesis by combining machine-learning molecular design with “Chemputation”—a closed-loop workflow designed to translate target molecules into executable, synthesis-aware chemical “code” that runs on Chemify’s robotic systems for automated Design–Make–Test–Analyze cycles. The company positions its core value proposition as eliminating the synthesis bottleneck (and related failure modes such as AI hallucinations) by making designs explicitly runnability/“makeability” constrained by validated, automated reaction knowledge. Chemify’s go-to-market centers on partner-driven discovery and synthesis programs (pharma/biotech and industrial/materials use cases), delivered through both software and physical lab capacity via Chemify’s Chemifarm facility in Glasgow. Chemify’s platform is packaged into a partner-facing product/workflow called Genesis, which the company describes as the full executable loop (route → executable chemistry → experiment → verification), with partner-specific “world model” data security/privacy controls.

News

Company record

Dec 10, 2025 · Official · Business WireChemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

Chemify announced a follow-on grant from the Bill & Melinda Gates Foundation of $1.6 million to continue tuberculosis small-molecule discovery using Chemify’s automated platform and Lgenia’s drug discovery expertise; Chemify said the total related funding for the effort is $3.2 million.

Jun 20, 2025 · Official · Reportable (Chemify press distribution)Chemify Launches the World’s First Chemputation Facility Revolutionizing Molecular Design and Manufacture

Chemify announced the unveiling of its first Chemifarm, a fully automated chemistry facility in Maryhill, Glasgow, describing the 21,500-ft² site, integration of Chemputation and robotic synthesis, and UK-government-linked funding and job figures referenced for the project.

Oct 01, 2024 · Official · Business WireChemify Receives Grant to Design and Discover New Drug Leads for Tuberculosis and Malaria Using Digital Chemistry Technology

Chemify announced a Gates Foundation grant to discover new drug leads for tuberculosis and malaria using Chemputation technology and described the aim of iteratively optimizing potential leads.

Jan 18, 2024 · Official · ChemifyChemify and Prepaire Labs Partner to Apply Chemistry AI-Robotics to Accelerate Discovery of Non-Addictive Opioids

Chemify announced an expansion of its partnership with Prepaire Labs to develop digitally discovered non-addictive opioids and related treatments, combining Chemify’s programmable chemistry platform with Prepaire’s drug discovery platform.

Sep 12, 2023 · Official · ChemifyChemify and Dewpoint Therapeutics Partner to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targeting Cancer and Neurodegeneration

Chemify announced a partnership with Dewpoint Therapeutics to apply Chemify’s programmable chemistry technology to accelerate discovery efforts targeting cancer and neurodegeneration (partnership page describes Dewpoint’s condensate-related approach).

Source map · 2 recurring channels · 20 references

Still resolving: Newsroom · Official X

What it builds

Chemputation Technology

Chemify’s Chemputation Technology translates target molecules into “proven chemical code” that runs directly on Chemify’s robotic systems, enabling fully automated Design–Make–Test–Analyze cycles, with synthesis-aware design and closed-loop iteration.

source ↗
χDL (universal chemical programming language)

χDL is Chemify’s described universal chemical programming language used to express synthesis procedures as standardized, hardware-agnostic chemical code that Chemify’s automation systems execute.

source ↗
ASSEMBLER (route optimization software)

ASSEMBLER is Chemify’s route-optimization software that selects synthetic paths using Chemify’s database of pre-validated and automated reaction classes.

source ↗
Genesis

Genesis is Chemify’s partner-facing “whole loop” workflow, described as an executable program for digital chemistry that pairs search/retrosynthesis and synthesis execution with a partner-owned “world model,” with security controls (encrypted and private-by-default).

source ↗
Chemifarm (automated synthesis facility)

Chemifarm is Chemify’s fully automated chemistry facility in Maryhill, Glasgow, intended to integrate Chemify’s Chemputation platform with industrial-scale robotic synthesis, including production suites, R&D labs, engineering/fabrication zones, and a secure cloud architecture for chemical data.

source ↗

Key metrics

Milestones & partnerships